Skip to content

Facilitating stress prevention in micro and small-sized enterprises: protocol for a mixed method study to evaluate the effectiveness and implementation process of targeted web-based interventions

Facilitating stress prevention in micro and small-sized enterprises: protocol for a mixed method study to evaluate the effectiveness and implementation process of targeted web-based interventions - PragmatiKK

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00026154
Enrollment
150
Registered
2021-09-16
Start date
2021-11-24
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depressive symptoms, work stress

Interventions

Group 1: Online stress management training (Get.On) with seven modules and online psychosocial risk assessment of the workplace

Sponsors

Universitätsklinikum Düsseldorf AÖRInstitut für Medizinische SoziologieCentre for Health and Society (chs)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to No maximum

Inclusion criteria

Inclusion criteria: Employee or manager in a small and micro enterprise

Exclusion criteria

Exclusion criteria: Interested parties who do not access the 'System P' home page through the planned structured approach may register to participate in the implementation study in 'System P', but will not be considered for the activation evaluation.

Design outcomes

Primary

MeasureTime frame
The primary outcome with regard to effectiveness will be the change in self-rated depressive symptoms between T1 and T2 (online questionnaire (baseline, 6 month, 12 month). Depression will be measured by the short version of the Patient Health Questionnaire (PHQ-8).

Secondary

MeasureTime frame
Secondary outcomes: Perceived Stress Scale (PSS-4), 4 items Irritation (subscale cognitive irritation), 3 items Psychological Safety Climate (PSC-4), 4 items Work demands and support (COPSOQ), 7 items Sickness absence and productivity (Tic-P), 6 items User experience, 11 items Process outcomes: Readiness for change, 3 items Adoption/Reach: The proportion of MSE who adopted “System P” will be calculated by dividing the number of registered MSE at T1 by the number of invited MSE during recruitment (R1). Appropriateness: To gain further information on appropriateness (perceived fit for the setting), we will conduct semi-structured personal interviews with employers of MSE that are registered with inter-corporate stakeholders who are unable contact their members via email newsletters at R1 as described above. Fidelity: To measure fidelity, we analyze usage data collected directly via “System P”. We will track data on the times of login, number of steps completed in the web-based tool for PRA and the number of completed sessions in the web-based training. Additionally, we will ask the participants about their use of the interventions in the online questionnaires at T2 and T3 (e.g. “How much time have you spent on average for the training?”). Costs: The direct costs of the implementation in “System P” are none because participating organizations will not be charged for the use of the web-based platform during the study. Indirect costs will be calculated by multiplying the time spent on the platform by the average hourly salary. The hours spent logged in to the web-based platform will be tracked for employers, employee and e-coaches. Feasibility & Sustainability: Feasibility and sustainability will be assessed by means of focus groups with a subsample of the participating MSE. All employers registered at T1 will receive an invitation to take part in the discussion about stress prevention and will be asked to describe their experience with “System P”.

Countries

Germany

Contacts

Public ContactInes Wulf

Universitätsklinikum Düsseldorf AÖRInstitut für Medizinische SoziologieCentre for Health and Society (chs)

Ines.Wulf@hhu.de+49-0211-81-06537

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 18, 2026